Research Funding
- NIH Director's Early Independence Award
- NIH Director's New Innovator Award
- NIH Director's Pioneer Award
- NIH Director's Transformative Research Award
- Bridge to Artificial Intelligence (Bridge2AI) Program
- Gabriella Miller Kids First Pediatric Research Program
- Illuminating the Druggable Genome Program
- NIH Faculty Institutional Recruitment for Sustainable Transformation
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa NewInnovatorAward@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa NewInnovatorAward@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2022 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) | 4/6/2021 | RFA-RM-21-015 | Ravi Basavappa PioneerAwards@mail.nih.gov 301-435-7204 |
9/10/2021 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa PioneerAwards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
Illuminating the Druggable Genome Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) | 4/1/2021 | RFA-RM-21-012 | Karlie Sharma DruggableGenome@mail.nih.gov 301-451-4965 |
Letter of Intent: 6/15/2021 Receipt Date: 7/15/2021 |
| Notice of Special Interest for Illuminating the Druggable Genome (IDG) Initiative: Request for Administrative Supplements to Existing Grants for incorporating single cell data into the IDG Knowledgebase | 4/2/2021 | NOT-RM-21-019 | DruggableGenome@mail.nih.gov | Receipt Date: 6/15/2021 |
| Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) | 4/5/2021 | RFA-RM-21-020 | Jerry Li DruggableGenome@mail.nih.gov 240-276-6210 |
Letter of Intent: 6/15/2021 Receipt Date: 7/15/2021 |
Bridge to Artificial Intelligence (Bridge2AI)
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| 4/8/2021 | NOT-RM-21-021 | Shurjo Sen bridge2ai@od.nih.gov 301-827-7028 |
N/A | |
| Notice of Intent to Publish a Research Opportunity Announcement for the Data Generation Projects of the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (OT2) | 4/8/2021 | NOT-RM-21-022 | Shurjo Sen bridge2ai@od.nih.gov 301-827-7028 |
N/A |
Gabriella Miller Kids First Pediatric Research Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| 2/8/2021 | RFA-RM-21-011 | Valerie Cotton valerie.cotton@nih.gov 301-594-1519 |
Letter of Intent: 5/18/2021 Receipt Date: 6/18/2021 |
NIH Faculty Institutional Recruitment for Sustainable Transformation
| Title | NIH Guide | RFA Number | NIH Contact | Estimated Receipt Date |
|---|---|---|---|---|
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) Notice of Expiration of RFA-RM-20-023 "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)" |
02/24/2021 | RFA-RM-21-019 | Rina Das FIRSTNIH@nih.gov 301-496-3996 |
Letter of Intent Receipt Date: |
Past Funding Opportunities
- 4D Nucleome
- Big Data to Knowledge
- Bioinformatics and Computational Biology
- Bridging Interventional Development Gaps (BrIDGs)
- Building Blocks, Biological Pathways and Networks
- Enhancing the Diversity of the NIH-Funded Workforce
- Epigenomics
- Extracellular RNA Communication
- Genotype-Tissue Expression (GTEx)
- Global Health
- Glycoscience
- Gulf Oil Spill
- HCS Research Collaboratory
- Health Economics
- High-Risk Research
- NIH Director’s Early Independence Award (EIA)
- NIH Director’s New Innovator Award
- NIH Director’s Pioneer Award
- NIH Director’s Transformative Research Awards
- Human Microbiome Project
- Illuminating the Druggable Genome
- Interdisciplinary Research
- Knockout Mouse Phenotyping
- Library of Integrated Network-Based Cellular Signatures (LINCS)
- Metabolomics
- Molecular Libraries and Imaging
- Nanomedicine
- NIH Center for Regenerative Medicine (NIH CRM)
- NIH Medical Research Scholars Program
- PROMIS: Patient-Reported Outcomes Measurement Information System
- Protein Capture Reagents
- Regulatory Science
- Science of Behavior Change
- Single Cell Analysis
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Strengthening the Biomedical Research Workforce
- Structural Biology
- Undiagnosed Diseases
Funded Research
- 4D Nucleome
- Big Data to Knowledge
- Bioinformatics and Computational Biology
- Bridging Interventional Development Gaps (BrIDGs)
- Building Blocks, Biological Pathways and Networks
- Enhancing the Diversity of the NIH-Funded Workforce
- Epigenomics
- Extracellular RNA Communication
- Gabriella Miller Kids First
- Genotype-Tissue Expression (GTEx)
- Global Health
- Glycoscience
- HCS Research Collaboratory
- Health Economics
- High-Risk Research:
- NIH Director’s Early Independence Award (EIA)
- NIH Director’s New Innovator Award
- NIH Director’s Pioneer Award
- NIH Director’s Transformative Research Awards
- Human Microbiome Project
- Illuminating the Druggable Genome
- Interdisciplinary Research
- Knockout Mouse Phenotyping
- Library of Integrated Network-Based Cellular Signatures (LINCS)
- Metabolomics
- Molecular Libraries and Imaging
- Molecular Transducers of Physical Activity in Humans
- Nanomedicine
- NIH Center for Regenerative Medicine (NIH CRM)
- NIH Medical Research Scholars Program
- PROMIS: Patient-Reported Outcomes Measurement Information System
- ProteinCapture Reagents
- Regulatory Science
- Science of Behavior Change
- Single Cell Analysis
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Strengthening the Biomedical Research Workforce
- Structural Biology
- Transformative High Resolution Cryo-Electron Microscopy
- Undiagnosed Diseases
This page last reviewed on April 8, 2021